Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating multiple myeloma using natural killer cells expressing a chimeric antigen receptor for CD38

Method of treating multiple myeloma using natural killer cells expressing a chimeric antigen receptor for CD38

US Patent 10799536 · Granted Oct 13, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified natural killer cells and natural killer cell lines having increased cyt2021
Modified natural killer cells and natural killer cell lines having increased cyt2021
Modified natural killer cells and natural killer cell lines having increased cyt2018
Concentrated cleaning compositions1994